(Q410400)

phenytoin (English)

3 October 2016

C₁₅H₁₂N₂O₂

1 reference

phenytoin (English)

19 November 2016

C1=CC=C(C=C1)C2(C(=O)NC(=O)N2)C3=CC=CC=C3

1 reference

phenytoin (English)

19 November 2016

296 degree Celsius

1 reference

Jean-Claude Bradley Open Melting Point Dataset

1 reference

14 February 2018

1 reference

14 February 2018

World Health Organisation international non-proprietary name

phenytoin (English)

1 reference

phenytoin (English)

medical condition treated

3 October 2016

2 references

13 December 2016

Drug Indications Extracted from FAERS

2 October 2018

epidermolysis bullosa

1 reference

13 December 2016

temporal lobe epilepsy

1 reference

Drug Indications Extracted from FAERS

13 December 2016

1 reference

significant drug interaction

2 October 2018

1 reference

A reference set of clinically relevant adverse drug-drug interactions

vincristine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

bortezomib

1 reference

A reference set of clinically relevant adverse drug-drug interactions

paclitaxel

1 reference

A reference set of clinically relevant adverse drug-drug interactions

cisplatin

1 reference

A reference set of clinically relevant adverse drug-drug interactions

metronidazole

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

vinblastine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

L-thyroxine

hypothyroidism

1 reference

A reference set of clinically relevant adverse drug-drug interactions

bazedoxifene

endometrial hyperplasia

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

physically interacts with

Sodium voltage-gated channel alpha subunit 2

role

channel blocker

1 reference

IUPHAR/BPS Guide to PHARMACOLOGY

Guide to Pharmacology Ligand ID

2624

Australian pregnancy category D

17 August 2016

pregnancy category

1 reference

imported from Wikimedia project

English Wikipedia

US pregnancy category D

1 reference

imported from Wikimedia project

1 reference

Medical Subject Headings

MeSH descriptor ID

D010672

voltage-gated sodium channel blockers

15 March 2018

1 reference

Medical Subject Headings

MeSH descriptor ID

D010672

cytochrome P-450 CYP1A2 inducers

15 March 2018

1 reference

Medical Subject Headings

MeSH descriptor ID

D010672

15 March 2018

developmental toxicant

start time

1 July 1987

1 reference

California Proposition 65 list of chemicals

https://oehha.ca.gov/chemicals/diphenylhydantoin

26 February 2020

reference URL

carcinogen

1 reference

California Proposition 65 list of chemicals

https://oehha.ca.gov/chemicals/diphenylhydantoin

26 February 2020

reference URL

essential medicine

0 references

Commons category

Phenytoin

0 references

Identifiers

InChI

InChI=1S/C15H12N2O2/c18-13-15(17-14(19)16-13,11-7-3-1-4-8-11)12-9-5-2-6-10-12/h1-10H,(H2,16,17,18,19)

1 reference

phenytoin (English)

19 November 2016

2 references

phenytoin (English)

19 November 2016

ChEBI release 2020-09-01

CAS Registry Number

57-41-0

2 references

https://commonchemistry.cas.org/detail?cas_rn=57-41-0

phenytoin (English)

19 November 2016

5 April 2021

1 reference

phenytoin (English)

3 October 2016

2 references

phenytoin (English)

19 November 2016

146015336

1 reference

Reaxys registry number

384532

1 reference

phenytoin (English)

3 October 2016

mapping relation type

2 references

PHENYTOIN (English)

19 November 2016

International Chemical Identifier

InChI

InChI=1S/C15H12N2O2/c18-13-15(17-14(19)16-13,11-7-3-1-4-8-11)12-9-5-2-6-10-12/h1-10H,(H2,16,17,18,19)

1 reference

PHENYTOIN (English)

19 November 2016

2 references

inferred from InChIKey

MSBNK-Fac_Eng_Univ_Tokyo-JP002791

1 reference

MassBank accession ID

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

MSBNK-Fac_Eng_Univ_Tokyo-JP003167

0 references

MSBNK-Fac_Eng_Univ_Tokyo-JP007973

0 references

MSBNK-Fac_Eng_Univ_Tokyo-JP007980

0 references

MSBNK-Fac_Eng_Univ_Tokyo-JP007986

0 references

MSBNK-Waters-WA001884

0 references

MSBNK-Waters-WA001885

0 references

MSBNK-Waters-WA001886

0 references

MSBNK-Waters-WA001887

0 references

MSBNK-Waters-WA001888

0 references

SPLASH

splash10-001i-0910000000-9edcfc62014a6aa7778f

0 references

splash10-001i-0900000000-d4dde5db680fb7722a49

0 references

splash10-0ue9-0900000000-482874b33812389ae726

0 references

splash10-0udi-0900000000-44f07dc29daf8cdf80c2

0 references

splash10-0udi-1900000000-1241292d531ed37544c7

0 references

splash10-0udi-0090000000-aaae845342f345f89695

0 references

splash10-0udi-0390000000-f8da1896c569c120faa2

0 references

splash10-0udi-0920000000-07c872b05aade63c402b

0 references

splash10-0udi-0900000000-be6790637be99260525e

0 references

splash10-0udi-0900000000-9a17fa0b243c8282f3ba

0 references

splash10-0udi-0900000000-69302626996b2b24c153

0 references

splash10-003r-7930000000-447969b9c242748dd943

0 references

splash10-0udi-0090000000-4176043a7a73caee2667

0 references

splash10-0zgi-5960000000-e1dcb47a1c082f04f456

0 references

splash10-0udi-1390000000-22c71a7e4dbf9c7acab5

0 references

splash10-0udi-2190000000-50174e33af92b04d1a6e

0 references

splash10-001i-0950000000-a80521d4dc3976a29b2c

0 references

splash10-0f89-4940000000-2a0dda513d9f63dc6610

0 references

NMRShiftDB structure ID

10021980

1 reference

Hazardous Substances Data Bank

0 references

1 reference

28 October 2019

PHENYTOIN (English)

10 May 2021

2 references

Mapping file of InChIStrings, InChIKeys and DTXSIDs for the EPA CompTox Dashboard

DSSTOX compound identifier

0 references

0 references

1 reference

phenytoin (English)

ECHA Substance Infocard ID

19 November 2016

100.000.298

1 reference

ECHA Substance Infocard database

ECHA Substance Infocard ID

27 December 2018

Phenytoin (English)

CAS no.: 57-41-0 (English)

1 reference

Guide to Pharmacology Ligand ID

Phenytoin (English)

publication date

17 November 2015

2624

1 reference

IUPHAR/BPS Guide to PHARMACOLOGY

Guide to Pharmacology Ligand ID

2624

D03.383.129.308.432.555.730

phenytoin (English)

19 November 2016

Phenytoin

0 references

MeSH concept ID

M0016580

0 references

MeSH tree code

0 references

RxNorm ID

8183

1 reference

phenytoin (English)

19 November 2016

1 reference

Human Metabolome Database ID

HMDB0014397

2 references

based on heuristic

inferred from InChIKey

2 references

phenytoin (English)

19 November 2016

MedlinePlus drug identifier

a682022

route of administration

oral administration

0 references

a619062

route of administration

intravenous injection

0 references

PatientsLikeMe treatment ID

0 references

1 reference

phenytoin (English)

19 November 2016

0 references

1 reference

1 reference

phenytoin (English)

3 October 2016

1 reference

Immune Epitope Database and Analysis Resource

phenytoin (English)

3 October 2016

1 reference

1 March 2022

1 reference

California Proposition 65 list of chemicals

https://oehha.ca.gov/chemicals/diphenylhydantoin

16 December 2019

reference URL

1 reference

6 April 2020

electronic Essential Medicines List medicine ID

54

0 references

Encyclopædia Britannica Online ID

science/phenytoin

subject named as

phenytoin

0 references

1 reference

28 October 2013

Interlingual Index ID

0 references

1 reference

9 July 2020

Microsoft Academic ID

0 references

1 reference

26 January 2022

https://docs.openalex.org/download-snapshot/snapshot-data-format

1 reference

Store medisinske leksikon ID

fenytoin

mapping relation type

exact match

subject named as

fenytoin

1 reference

Great Norwegian Encyclopedia

UK Parliament thesaurus ID

29 May 2020

368435

subject named as

Phenytoin

0 references

UMLS CUI

C0031507

1 reference

phenytoin (English)

19 November 2016

0 references

WordNet 3.1 Synset ID

03208125-n

1 reference